Expert Interview
A look at the potential of Zanubrutinib(BRUKINSA®) and the phase 3 ALPINE trial presented at the ASH 2022 conference in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
Ticker(s): BGNEInstitution: Cochise Oncology
- Hematologist/Oncology specialist and a Hematologist in Garden City, Michigan.
- Goldfarb has been practicing medicine for over 52 years and is highly rated in 14 conditions
- Top areas of expertise are Lung Cancer, Paget Disease of the Breast, Lung Adenocarcinoma, and Small Cell Lung Cancer SCLC.
- Manages 14 patients with multiple myeloma and currently prescribes tecvayil
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
